OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Differential Effects of GLP-1 Receptor Agonists on Cancer Risk in Obesity: A Nationwide Analysis of 1.1 Million Patients
Shauna Levy, Abdallah S. Attia, Rami M. Elshazli, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 78-78
Open Access | Times Cited: 5
Shauna Levy, Abdallah S. Attia, Rami M. Elshazli, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 78-78
Open Access | Times Cited: 5
Showing 5 citing articles:
Obesity and Cancer: Excess Body Fat as a Risk Factor in Carcinogenesis; Consequences Across Human Body Systems and Significance for Associated Medical Specialties
Nicholas A Kerna, Taylor M. Nicely, Uwakmfonabasi Umoudoh, et al.
European Journal of Medical and Health Research (2025) Vol. 3, Iss. 2, pp. 122-135
Closed Access
Nicholas A Kerna, Taylor M. Nicely, Uwakmfonabasi Umoudoh, et al.
European Journal of Medical and Health Research (2025) Vol. 3, Iss. 2, pp. 122-135
Closed Access
Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Cancer Prevention: Methodological Pitfalls in Observational Studies
Matthew Harris, Michelle Harvie, Andrew G. Renehan
Cancers (2025) Vol. 17, Iss. 9, pp. 1451-1451
Open Access
Matthew Harris, Michelle Harvie, Andrew G. Renehan
Cancers (2025) Vol. 17, Iss. 9, pp. 1451-1451
Open Access
Dietary and pharmacological energy restriction and exercise for healthspan extension
María Lastra Cagigas, Isabella De Ciutiis, Andrius Masedunskas, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
María Lastra Cagigas, Isabella De Ciutiis, Andrius Masedunskas, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
May Patients Receiving GLP-1 Agonists Be at Lower Risk of Prostate Cancer Aggressiveness and Progression?
Julia Drewa, Katarzyna Lazar-Juszczak, Jan Adamowicz, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1576-1576
Open Access
Julia Drewa, Katarzyna Lazar-Juszczak, Jan Adamowicz, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1576-1576
Open Access
Survival Benefits of GLP-1 Receptor Agonists in Patients with Neuroendocrine Neoplasms: A Large-Scale Propensity-Matched Cohort Study
Manal S. Fawzy, Awwad Alenezy, Jessan A. Jishu, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1593-1593
Open Access
Manal S. Fawzy, Awwad Alenezy, Jessan A. Jishu, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1593-1593
Open Access
